# NET-PD LS-1 Creatine in Parkinson's Disease

> **NCT00449865** · PHASE3 · TERMINATED · sponsor: **University of Rochester** · enrollment: 1741 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** creatine
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT00449865
- **Lead sponsor:** University of Rochester
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-03
- **Primary completion:** 2013-09
- **Final completion:** 2014-05
- **Target enrollment:** 1741 (ACTUAL)
- **Why stopped:** Futility
- **Last updated:** 2015-04-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00449865

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00449865, "NET-PD LS-1 Creatine in Parkinson's Disease". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00449865. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*